Informax Licenses Genomax to Cellular Genomics | GenomeWeb

NEW YORK, May 14 – Bioinformatics company Informax said Monday it signed a deal in the first quarter to license its Genomax software to Cellular Genomics.

An Informax spokeswoman said the deal was recorded in the company’s first quarter earnings although the official announcement was held up due to internal delays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.